Researchers decry ‘disastrously bad idea’ as NIH slashes payments for research infrastructure
The US National Institutes of Health is lowering the maximum “indirect cost rate” that research institutions can charge the ...
MedPage Today23h
Gene Therapy May Be a Game Changer for Transfusion-Dependent Thalassemia
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...